Controlled Hypertension, a Transgenic Toggle Switch Reveals Differential Mechanisms Underlying Vascular Disease
Open Access
- 1 September 2001
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (39) , 36727-36733
- https://doi.org/10.1074/jbc.m103296200
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Genetic mapping of modifier loci affecting malignant hypertension in TGRmRen2 ratsKidney International, 1999
- Hypertension-Induced End-Organ DamageHypertension, 1999
- High Human Renin Hypertension in Transgenic RatsHypertension, 1997
- Polymorphic forms of the Ah receptor and induction of the CYP1A1 genePharmacogenetics, 1995
- Transgenic Rats: New Experimental Models for the Study of Candidate Genes in Hypertension ResearchAnnual Review of Physiology, 1994
- Increased adrenal renin in transgenic hypertensive rats, TGR(mREN2)27, and its regulation by cAMP, angiotensin II, and calcium.Journal of Clinical Investigation, 1993
- Ah receptor binding properties of indole carbinols and induction of hepatic estradiol hydroxylationBiochemical Pharmacology, 1993
- Malignant hypertensive crisis induced by chronic intrarenal norepinephrine infusion.Hypertension, 1984
- Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes.Circulation Research, 1975
- THE NATURE OF MALIGNANCY IN HYPERTENSIVE DISEASE: Evidence from the Retina of the RatThe Lancet, 1963